img

Global Anti-TNF-α Monoclonal Antibody Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-TNF-α Monoclonal Antibody Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-TNF-α Monoclonal Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-TNF-α Monoclonal Antibody market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Rheumatoid Arthritis and Ankylosing Spondylitis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-TNF-α Monoclonal Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-TNF-α Monoclonal Antibody key manufacturers include Abbive, Johnson and Johnson and UCB, etc. Abbive, Johnson and Johnson, UCB are top 3 players and held % sales share in total in 2022.
Anti-TNF-α Monoclonal Antibody can be divided into Adalimumab, Golimumab, Infliximab and Pecerizumab, etc. Adalimumab is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-TNF-α Monoclonal Antibody is widely used in various fields, such as Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis and Other, etc. Rheumatoid Arthritis provides greatest supports to the Anti-TNF-α Monoclonal Antibody industry development. In 2022, global % sales of Anti-TNF-α Monoclonal Antibody went into Rheumatoid Arthritis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-TNF-α Monoclonal Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbive
Johnson and Johnson
UCB
Segment by Type
Adalimumab
Golimumab
Infliximab
Pecerizumab

Segment by Application


Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriasis
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-TNF-α Monoclonal Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-TNF-α Monoclonal Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-TNF-α Monoclonal Antibody industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Anti-TNF-α Monoclonal Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-TNF-α Monoclonal Antibody introduction, etc. Anti-TNF-α Monoclonal Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anti-TNF-α Monoclonal Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Anti-TNF-α Monoclonal Antibody Market Overview
1.1 Anti-TNF-α Monoclonal Antibody Product Overview
1.2 Anti-TNF-α Monoclonal Antibody Market Segment by Type
1.2.1 Adalimumab
1.2.2 Golimumab
1.2.3 Infliximab
1.2.4 Pecerizumab
1.3 Global Anti-TNF-α Monoclonal Antibody Market Size by Type
1.3.1 Global Anti-TNF-α Monoclonal Antibody Market Size Overview by Type (2024-2034)
1.3.2 Global Anti-TNF-α Monoclonal Antibody Historic Market Size Review by Type (2024-2024)
1.3.3 Global Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.2 Europe Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Breakdown by Type (2024-2024)
2 Global Anti-TNF-α Monoclonal Antibody Market Competition by Company
2.1 Global Top Players by Anti-TNF-α Monoclonal Antibody Sales (2024-2024)
2.2 Global Top Players by Anti-TNF-α Monoclonal Antibody Revenue (2024-2024)
2.3 Global Top Players by Anti-TNF-α Monoclonal Antibody Price (2024-2024)
2.4 Global Top Manufacturers Anti-TNF-α Monoclonal Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-TNF-α Monoclonal Antibody Market Competitive Situation and Trends
2.5.1 Anti-TNF-α Monoclonal Antibody Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-TNF-α Monoclonal Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-TNF-α Monoclonal Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-TNF-α Monoclonal Antibody Market
2.8 Key Manufacturers Anti-TNF-α Monoclonal Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-TNF-α Monoclonal Antibody Status and Outlook by Region
3.1 Global Anti-TNF-α Monoclonal Antibody Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Anti-TNF-α Monoclonal Antibody Historic Market Size by Region
3.2.1 Global Anti-TNF-α Monoclonal Antibody Sales in Volume by Region (2024-2024)
3.2.2 Global Anti-TNF-α Monoclonal Antibody Sales in Value by Region (2024-2024)
3.2.3 Global Anti-TNF-α Monoclonal Antibody Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Region
3.3.1 Global Anti-TNF-α Monoclonal Antibody Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-TNF-α Monoclonal Antibody Sales in Value by Region (2024-2034)
3.3.3 Global Anti-TNF-α Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-TNF-α Monoclonal Antibody by Application
4.1 Anti-TNF-α Monoclonal Antibody Market Segment by Application
4.1.1 Rheumatoid Arthritis
4.1.2 Ankylosing Spondylitis
4.1.3 Psoriasis
4.1.4 Other
4.2 Global Anti-TNF-α Monoclonal Antibody Market Size by Application
4.2.1 Global Anti-TNF-α Monoclonal Antibody Market Size Overview by Application (2024-2034)
4.2.2 Global Anti-TNF-α Monoclonal Antibody Historic Market Size Review by Application (2024-2024)
4.2.3 Global Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.2 Europe Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Breakdown by Application (2024-2024)
5 North America Anti-TNF-α Monoclonal Antibody by Country
5.1 North America Anti-TNF-α Monoclonal Antibody Historic Market Size by Country
5.1.1 North America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2024)
5.1.3 North America Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2024)
5.2 North America Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Country
5.2.1 North America Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2034)
6 Europe Anti-TNF-α Monoclonal Antibody by Country
6.1 Europe Anti-TNF-α Monoclonal Antibody Historic Market Size by Country
6.1.1 Europe Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2024)
6.1.3 Europe Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2024)
6.2 Europe Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Country
6.2.1 Europe Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-TNF-α Monoclonal Antibody by Region
7.1 Asia-Pacific Anti-TNF-α Monoclonal Antibody Historic Market Size by Region
7.1.1 Asia-Pacific Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales in Value by Region (2024-2034)
8 Latin America Anti-TNF-α Monoclonal Antibody by Country
8.1 Latin America Anti-TNF-α Monoclonal Antibody Historic Market Size by Country
8.1.1 Latin America Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2024)
8.1.3 Latin America Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2024)
8.2 Latin America Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Country
8.2.1 Latin America Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-TNF-α Monoclonal Antibody by Country
9.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Historic Market Size by Country
9.1.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbive
10.1.1 Abbive Company Information
10.1.2 Abbive Introduction and Business Overview
10.1.3 Abbive Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Abbive Anti-TNF-α Monoclonal Antibody Products Offered
10.1.5 Abbive Recent Development
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Company Information
10.2.2 Johnson and Johnson Introduction and Business Overview
10.2.3 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Products Offered
10.2.5 Johnson and Johnson Recent Development
10.3 UCB
10.3.1 UCB Company Information
10.3.2 UCB Introduction and Business Overview
10.3.3 UCB Anti-TNF-α Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.3.4 UCB Anti-TNF-α Monoclonal Antibody Products Offered
10.3.5 UCB Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-TNF-α Monoclonal Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-TNF-α Monoclonal Antibody Industrial Chain Analysis
11.4 Anti-TNF-α Monoclonal Antibody Market Dynamics
11.4.1 Anti-TNF-α Monoclonal Antibody Industry Trends
11.4.2 Anti-TNF-α Monoclonal Antibody Market Drivers
11.4.3 Anti-TNF-α Monoclonal Antibody Market Challenges
11.4.4 Anti-TNF-α Monoclonal Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-TNF-α Monoclonal Antibody Distributors
12.3 Anti-TNF-α Monoclonal Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Adalimumab
Table 2. Major Company of Golimumab
Table 3. Major Company of Infliximab
Table 4. Major Company of Pecerizumab
Table 5. Global Anti-TNF-α Monoclonal Antibody Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (KG)
Table 7. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (US& Million)
Table 9. Global Anti-TNF-α Monoclonal Antibody Market Share in Value by Type (2024-2024)
Table 10. Global Anti-TNF-α Monoclonal Antibody Price by Type (2024-2024) & (USD/KG)
Table 11. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2034) & (KG)
Table 12. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type (2024-2034)
Table 15. Global Anti-TNF-α Monoclonal Antibody Price by Type (2024-2034) & (USD/KG)
Table 16. North America Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (KG)
Table 17. North America Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Anti-TNF-α Monoclonal Antibody Sales (KG) by Type (2024-2024)
Table 19. Europe Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales (KG) by Type (2024-2024)
Table 21. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Anti-TNF-α Monoclonal Antibody Sales (KG) by Type (2024-2024)
Table 23. Latin America Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales (KG) by Type (2024-2024)
Table 25. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Anti-TNF-α Monoclonal Antibody Sales by Company (2024-2024) & (KG)
Table 27. Global Anti-TNF-α Monoclonal Antibody Sales Share by Company (2024-2024)
Table 28. Global Anti-TNF-α Monoclonal Antibody Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Company (2024-2024)
Table 30. Global Market Anti-TNF-α Monoclonal Antibody Price by Company (2024-2024) & (USD/KG)
Table 31. Global Anti-TNF-α Monoclonal Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Anti-TNF-α Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-TNF-α Monoclonal Antibody as of 2022)
Table 34. Date of Key Manufacturers Enter into Anti-TNF-α Monoclonal Antibody Market
Table 35. Key Manufacturers Anti-TNF-α Monoclonal Antibody Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Anti-TNF-α Monoclonal Antibody Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2024) & (KG)
Table 39. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Region (2024-2024)
Table 42. Global Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2024-2024)
Table 43. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2034) & (KG)
Table 44. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Region (2024-2034)
Table 47. Global Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2024-2034)
Table 48. Global Anti-TNF-α Monoclonal Antibody Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) & (KG)
Table 50. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application (2024-2024)
Table 53. Global Anti-TNF-α Monoclonal Antibody Price by Application (2024-2024) & (USD/KG)
Table 54. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2034) & (KG)
Table 55. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application (2024-2034)
Table 58. Global Anti-TNF-α Monoclonal Antibody Price by Application (2024-2034) & (USD/KG)
Table 59. North America Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) (KG)
Table 60. North America Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) (KG)
Table 62. Europe Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) (KG)
Table 64. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) (KG)
Table 66. Latin America Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) (KG)
Table 68. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (KG)
Table 70. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 73. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (KG)
Table 74. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (KG)
Table 78. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (KG)
Table 82. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2024) & (KG)
Table 86. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2034) & (KG)
Table 90. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (KG)
Table 94. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (KG)
Table 98. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (KG)
Table 102. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (KG)
Table 106. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 109. Abbive Company Information
Table 110. Abbive Introduction and Business Overview
Table 111. Abbive Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 112. Abbive Anti-TNF-α Monoclonal Antibody Product
Table 113. Abbive Recent Development
Table 114. Johnson and Johnson Company Information
Table 115. Johnson and Johnson Introduction and Business Overview
Table 116. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 117. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product
Table 118. Johnson and Johnson Recent Development
Table 119. UCB Company Information
Table 120. UCB Introduction and Business Overview
Table 121. UCB Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (Million USD), Price (USD/KG) and Gross Margin (2024-2024)
Table 122. UCB Anti-TNF-α Monoclonal Antibody Product
Table 123. UCB Recent Development
Table 124. Key Raw Materials Lists
Table 125. Raw Materials Key Suppliers Lists
Table 126. Anti-TNF-α Monoclonal Antibody Market Trends
Table 127. Anti-TNF-α Monoclonal Antibody Market Drivers
Table 128. Anti-TNF-α Monoclonal Antibody Market Challenges
Table 129. Anti-TNF-α Monoclonal Antibody Market Restraints
Table 130. Anti-TNF-α Monoclonal Antibody Distributors List
Table 131. Anti-TNF-α Monoclonal Antibody Downstream Customers
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-TNF-α Monoclonal Antibody Product Picture
Figure 2. Global Anti-TNF-α Monoclonal Antibody Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-TNF-α Monoclonal Antibody Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Anti-TNF-α Monoclonal Antibody Sales Status and Outlook (2024-2034) & (KG)
Figure 5. Product Picture of Adalimumab
Figure 6. Global Adalimumab Sales YoY Growth (2024-2034) & (KG)
Figure 7. Product Picture of Golimumab
Figure 8. Global Golimumab Sales YoY Growth (2024-2034) & (KG)
Figure 9. Product Picture of Infliximab
Figure 10. Global Infliximab Sales YoY Growth (2024-2034) & (KG)
Figure 11. Product Picture of Pecerizumab
Figure 12. Global Pecerizumab Sales YoY Growth (2024-2034) & (KG)
Figure 13. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type in 2022 & 2034
Figure 15. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 16. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 17. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 21. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-TNF-α Monoclonal Antibody Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-TNF-α Monoclonal Antibody Revenue in 2022
Figure 27. Anti-TNF-α Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Rheumatoid Arthritis
Figure 29. Global Rheumatoid Arthritis Sales YoY Growth (2024-2034) & (KG)
Figure 30. Product Picture of Ankylosing Spondylitis
Figure 31. Global Ankylosing Spondylitis Sales YoY Growth (2024-2034) & (KG)
Figure 32. Product Picture of Psoriasis
Figure 33. Global Psoriasis Sales YoY Growth (2024-2034) & (KG)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2024-2034) & (KG)
Figure 36. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application in 2022 & 2034
Figure 38. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Anti-TNF-α Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Anti-TNF-α Monoclonal Antibody Manufacturing Cost Structure
Figure 49. Anti-TNF-α Monoclonal Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed